Form 4: 89bio Officer's Stock Withholding for Taxes
Insider Transaction Report
An 89bio, Inc. officer had shares withheld from restricted stock unit vesting to cover tax obligations.
Summary
- Quoc Le-Nguyen, Chief Technical Operations Officer of 89bio, Inc., had shares withheld on August 1, 2025.
- A total of 7,680 shares of common stock were withheld from direct ownership and 522 shares from indirect ownership (by spouse).
- The shares were withheld at a price of $9.16 per share.
- This action was to cover estimated tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, Quoc Le-Nguyen directly owns 301,684 shares and indirectly owns 13,694 shares through a spouse.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction (shares withheld for tax obligations upon RSU vesting), which is neutral in sentiment. It indicates continued equity compensation for an officer but does not reflect positive or negative operational or financial performance.
Positives
- The transaction indicates the vesting of restricted stock units, which implies continued employment and potential long-term commitment of the officer.
Negatives
- No direct negatives are indicated by a routine tax withholding transaction.
Risks
- No specific risks are mentioned in this Form 4 filing.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance.
Industry Context
This routine insider transaction, specifically a tax withholding related to RSU vesting, is a common occurrence across all industries for executives receiving equity compensation. It does not provide specific insights into broader industry trends or competitive dynamics for the biotechnology sector.
Comparison to Industry Standards
- This type of transaction (shares withheld for tax obligations upon RSU vesting) is a standard practice for equity compensation across publicly traded companies globally. It is not comparable to specific company projects or financial results.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Technical Operations Officer | NA | Quoc Le-Nguyen | NA | No change reported; filing identifies current role. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- No legal proceedings or regulatory matters are mentioned in this filing.
Related Party Transactions
- No related party dealings are disclosed beyond the routine equity compensation transaction for an officer.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine tax-related transaction for an executive's equity compensation.
- Employees: No direct impact on the broader employee base.
- Customers/Suppliers/Creditors: No direct impact.
Next Steps
- No specific future actions, events, or milestones are mentioned in this filing.
Key Dates
| Date | Description |
|---|---|
| 08/01/2025 | Date of transaction for stock withholding. |
| 08/05/2025 | Signature date of the reporting person's attorney-in-fact. |
Keywords
89bio, ETNB, Form 4, SEC filing, insider transaction, stock withholding, restricted stock units, tax obligation, Quoc Le-Nguyen, Chief Technical Operations Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.